从知识价值链视角看藏药新药研发策略

The research and development strategy of tibetan new drugs from the perspective of knowledge value chain

本文分析了藏药新药研发的特点和藏药临床价值形成过程,提出在当前藏药产业规模小、知识壁垒高、藏药新药研发低迷的背景下,应从知识价值链的角度加强对藏药新药研发过程的认识,重视藏药新药的研究阶段,重视藏医临床诊疗知识的现代医学转化,通过不断的藏西知识转化、结合和积累,逐步实现新药临床价值的清晰化,实现藏药新药上市。

This paper analyses the characteristics of the research and development of new Tibetan medicine and the forming process of its clinical value.It points out that currently Tibetan medicine industry is small in scale,high in knowledge barrier and low in research and development of new Tibetan medicine.In this context,we should strengthen our understanding of the research and development process of new Tibetan medicines from the perspective of knowledge value chain,pay attention to the research stage of new Tibetan medicines,and attach great importance to the modern medical transformation of clinical diagnosis and treatment knowledge of Tibetan medicine.By constantly transforming and combing the knowledge of Tibetan medicine and Western medicine,and accumulating it,we can gradually clarify the clinical value of new Tibetan drugs and get them approved.